Patent · US Active

Bupropion hydrobromide and therapeutic applications

US7671094B2 · kind B2 · utility

5Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 7, 2007
Grant dateMar 2, 2010
Priority date
Expiry dateAug 7, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.